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ABSTRACT 
EFFECT OF ANTIOXIDANTS LIKE α-TOCOPHEROL AND ASCORBIC 
ACID IN REDUCING THE PROGRESSION OF VASCULAR DEMENTIA 
AND ASCERTAIN THE MORPHOLOGICAL CHANGES IN THE RED 
BLOOD CELLS AS OXIDATIVE STRESS MARKER- A RANDOMIZED, 
OPEN LABEL, COMPARATIVE PILOT STUDY. 
Dr. B. Vasanthi ,  Dr. S. Gomathi. 
INTRODUCTION:  
 Dementia is characterised by progressive cognitive impairment in the presence 
of clear consciousness. Vascular dementia is the second most common type of 
dementia. Vascular dementia follows either a clinical stroke or a subclinical vascular 
brain injury in patients with risk factors like Diabetes mellitus and Systemic 
Hypertension. Oxidative stress is increased generation of free radicals in the body. It 
plays a significant role in the pathogenesis of not only vascular dementia but also its 
risk factors, hypertension and diabetes mellitus. Red blood cells (RBC) are the first in 
the body to get exposed to oxidative stress and the free radical injury to RBCs causes 
haemolytic anemia in diabetic patients. These structurally damaged RBCs serve as 
marker of oxidative stress. Vitamin C and Vitamin E serve as antioxidants due to 
their ability to scavenge free radicals. They correct the haemolytic anemia and also 
prevent oxidative stress induced cerebral ischemia.  Supplementation of vitamin C and 
Vitamin E in patients of vascular dementia therefore prevents the further progression 
of the disease. 
METHODS: 
 In this study, 60 patients of Mild Vascular Neurocognitive Impairment (VNCI) 
satisfying the Diagnostic and Statistical manual of mental disorder(DSM-5) criteria 
for mild VNCI, with Hypertension and Type 2 Diabetes mellitus as the vascular risk 
factors and in the age group of 60 to 70 years were included. They were randomised 
into control group of 30 patients who received the standard treatment for 
cerebrovascular disease (anti-diabetic, anti-hypertensive with/without  antiplatelet 
drug therapy) and the study group of 30 patients who received the vitamin C 500mg 
once daily and vitamin E 400mg once daily along with the standard treatment, for a 
period of 12 weeks and followed up for one month after stopping the study drugs. The 
RBC morphology of the patients in both groups were studied under high power 
microscope and percentage of dysmorphic RBCs were noted. The cognition status of 
the patients in both groups were assessed by a 30 point questionnaire based on Mini 
Mental Status Examination (in regional language) at the beginning of study and at the 
end of every month till 16 weeks. Other parameters like Blood pressure, fasting and 
postprandial blood glucose levels, Haemoglobin, RBC counts, Lipid profile, Liver 
function test, Renal function test  were also assessed during the study.  
 
 
RESULTS: 
There was a significant reduction in the percentage of dysmorphic RBCs in 
the study group (from 73% to 7.23%, p value= <0.05) at the end of 12weeks in 
comparison to the control group. The mean haemoglobin improved from 10.53 g/dl to 
12.43 g/dl in the study group (p=<0.05) at the end of 12 weeks. The mean fasting 
blood glucose decreased from 148.03 mg/dl to 118.87 mg/dl (p=<0.05) in the study 
group at the end of 12 weeks of treatment. There was a greater reduction in the blood 
glucose levels in the study group compared to the control group. The cognition 
assessment scores improved in the study group at the end of 12 weeks , from a mean 
score of 20 to 22.43 which was statistically significant (p=<0.05). In the control group 
the score decreased from a mean of 19.80 to 19.73 at the end of 12 weeks of 
treatment. The systolic and diastolic blood pressures also reduced significantly in the 
study group at the end of 12 weeks of treatment , as compared to the control group. 
There was significant reduction in haemolytic anemia at the end of 12 weeks of 
treatment with vitamin C(Ascorbic acid) and Vitamin E(α Tocopherol). The cognition 
status showed a significant improvement in the study group at the end of 12 weeks. 
All these beneficial effects were sustained during the four weeks follow up period. 
Antioxidants,vitamin C and vitamin E supplementation thus improves the memory 
and cognition, reducing the progression of vascular dementia. 
 
KEY WORDS:  Vascular dementia, Oxidative stress, Antioxidants,  Ascorbic 
acid, α-Tocopherol, Cognition, Diabetes mellitus, Systemic hypertension, vascular 
neurocognitive impairment, cerebral ischemia. 
